costs of split?, page-9

Cheers KW, remember we have always got beer, there's always the beer to look forward to:)

TonyW, I sometimes don't know how you come to you conclusions about me, I had talked about the split on a fair few occasions with many here including Higgins after he/she had asked me back in October. This was one of my points to Higgins back on the 26th Oct, granted it's not a partner as such but we now have some startegic US investors:

24/10

As far as underlying value I couldn't agree more. If for instance we get a split and partner the oncology, as has been discussed on here, we would see fonda earnings going straight back to the company without having to pay off any debt facility as the partner would have stumped up for the rights. So the fonda earnings could, in time, be distributed back to the shareholders by way of dividends, also this would strengthen the sp back to where it should be. This would give more certainty to shareholders as we navigate through hard economic times where companies get belted due to market sentiment.

Sure this would mean that "if" or should I say "when" HA-I is successful in phase 3 trials we would not hold 100% of it anymore, but the opportunity would still be substantial and we could all have been collecting dividends by then from fonda as this opportunity is years out.